CSI Market
Sign In | Register

Psychemedics (PMD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PMD Annual Cash Flow →
Reviewing cash flow figures over time highlights how Psychemedics balances operational cash generation with investment and financing decisions.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income-1.86
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Intangible Assets0.00
Share-based Compensation0.92
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Increase Decrease In Operating Lease R O U Assets And Liabilities-
Depreciation And Amortization Excluding Rou Asset Amortization0.92
Operating Lease Right Of Use Asset Amortization Expense0.75
Increase Decrease In Operating Lease Liabilities-
Increase Decrease In Operating Lease Liability-0.87
Operating Lease Payments0.65
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable1.18
Increase (Decrease) in Accounts Payable-0.29
Increase (Decrease) in Accrued Liabilities0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.82
Other Working Capital0.09
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-1.05
Discontinued operations0.00
Net Cash flow from Operating Activities0.93
Investing Activities
Capital Expenditures-0.09
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Proceeds From Sale Of Other Assets-
Payments For Proceeds From Sale Of Other Assets-
Write Off Capitalized Patent Costs-
Payments For Proceeds From Other Assets-0.10
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Assets, Investing Activities0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.09
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.48
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-0.63
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.01
Payments For Repurchase Of Common Stock For Employee Tax Withholding Obligations-
Proceeds From Repurchase Of Common Stock-
Proceeds From Equipment Financing-
Payments Of Equipment Financing-0.23
Proceeds From Payments For Issuance Of Stock Net Of Tax Withholding-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-1.39
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow0.84
Total Cash Flow-0.55
4 historic quarters locked

Sign in to unlock the full Psychemedics cash flow history.

Sign In Create Free Account

About Psychemedics Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001171843-24-006286

Figures are derived from filed reports and may be restated. Historical data is subject to revision.